Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-04-24

Clinical Trial Update: A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating pregabalin (Lyrica) for sleep problems in patients with sleep disorders and epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lyrica (Pregabalin)

Snippet

Sponsor: Pfizer | Conditions: Sleep Deprivation, Epilepsies, Partial | Phase 3 | Status: COMPLETED